ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Pramipexole Pilot Phase II Study in Children and Adolescents With Tourette Disorder According to DSM-IV Criteria

This study is currently recruiting participants.
Study NCT00558467.   Last updated on November 20, 2008.   Information provided by Boehringer Ingelheim Pharmaceuticals
Please refer to this study by its ClinicalTrials.gov identifier: NCT00558467


Contacts
Contact: Boehringer Ingelheim Study Coordinator     clintriage.rdg@boehringer-ingelheim.com    

Locations
United States, Florida
248.644.0025 Boehringer Ingelheim Investigational Site     Recruiting
      Tampa, Florida, United States
248.644.0026 Boehringer Ingelheim Investigational Site     Recruiting
      Bradenton, Florida, United States
248.644.0028 Boehringer Ingelheim Investigational Site     Recruiting
      Miami, Florida, United States
United States, Georgia
248.644.0006 Boehringer Ingelheim Investigational Site     Recruiting
      Columbus, Georgia, United States
United States, Illinois
248.644.0012 Boehringer Ingelheim Investigational Site     Recruiting
      Chicago, Illinois, United States
United States, Maryland
248.644.0016 Boehringer Ingelheim Investigational Site     Recruiting
      Baltimore, Maryland, United States
United States, Massachusetts
248.644.0005 Boehringer Ingelheim Investigational Site     Recruiting
      Cambridge, Massachusetts, United States
United States, New York
248.644.0001 Boehringer Ingelheim Investigational Site     Recruiting
      Rochester, New York, United States
248.644.0003 Boehringer Ingelheim Investigational Site     Recruiting
      Manhasset, New York, United States
248.644.0009 Boehringer Ingelheim Investigational Site     Recruiting
      New York, New York, United States
248.644.0013 Boehringer Ingelheim Investigational Site     Recruiting
      Orangeburg, New York, United States
248.644.0017 Boehringer Ingelheim Investigational Site     Recruiting
      Albany, New York, United States
248.644.0018 Boehringer Ingelheim Investigational Site     Recruiting
      New York, New York, United States
United States, Ohio
248.644.0027 Boehringer Ingelheim Investigational Site     Recruiting
      Cleveland, Ohio, United States
United States, Oklahoma
248.644.0029 Boehringer Ingelheim Investigational Site     Recruiting
      Oklahoma City, Oklahoma, United States
United States, Pennsylvania
248.644.0021 Boehringer Ingelheim Investigational Site     Not yet recruiting
      Pittsburgh, Pennsylvania, United States
United States, Rhode Island
248.644.0010 Boehringer Ingelheim Investigational Site     Recruiting
      Providence, Rhode Island, United States
United States, Tennessee
248.644.0030 Boehringer Ingelheim Investigational Site     Recruiting
      Memphis, Tennessee, United States
United States, Texas
248.644.0008 Boehringer Ingelheim Investigational Site     Recruiting
      Houston, Texas, United States
248.644.0032 Boehringer Ingelheim Investigational Site     Not yet recruiting
      Houston, Texas, United States
United States, Virginia
248.644.0023 Boehringer Ingelheim Investigational Site     Recruiting
      Norfolk, Virginia, United States
Germany
248.644.49001 Boehringer Ingelheim Investigational Site     Not yet recruiting
      Hannover, Germany
248.644.49004 Boehringer Ingelheim Investigational Site     Not yet recruiting
      Ulm, Germany

Sponsors and Collaborators
Boehringer Ingelheim Pharmaceuticals

Investigators
Study Chair:     Boehringer Ingelheim     Boehringer Ingelheim Pharmaceuticals    


U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act
U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services



Links to all studies - primarily for crawlers